New York Life Investment Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
New York Life Investment Management LLC
- $10.8 Billion
- Q3 2025
A detailed history of New York Life Investment Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 1,610 shares of MDGL stock, worth $852,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,610
Previous 1,653
2.6%
Holding current value
$852,028
Previous $500,000
47.6%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
405Shares Held
23.1MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$970 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...